Partnering
Contact
Contact Information
Join Us
EN
CN
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
Southeast Asia Business
News
Company News
Partner News
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Home
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
News
Company News
Partner News
Investors
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Partnering
Contact
Contact Information
Join Us
EN
CN
Information Disclosure
Announcements and Circulars
Financial Reports
Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Voluntary and Business Update Announcement New Drug Application of Diazepam Nasal Spray Approved in China
2023-06-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-06-01
Voluntary and Business Update Announcement New Drug Application of Tildrakizumab Injection Approved in China
2023-05-30
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
2023-05-04
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
2023-04-28
ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 APRIL 2023
2023-04-28
Voluntary and Business Update Announcement Ophthalmic Tetravalent Bispecific Antibody Product Being Granted an Approval for Drug Clinical Trial
2023-04-27
NOTIFICATION LETTER
2023-04-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
2023-04-06
NOTIFICATION LETTER
2023-04-06